Presenter: Dr. Simon B. Sherry, Professor at Dalhousie University and Psychologist at CRUX Psychology.
Major Depression Recovery:
60% of individuals with major depression benefit from psychotherapy (Comer, 2010).
Commonly, treatment spans 25 one-hour sessions over 25 weeks.
The combination of psychotherapy and antidepressants results in a 10% increased recovery rate (Hollon et al., 2002).
High relapse rates (>50%) are present post-treatment (Barlow et al., 2006).
Behavioral Therapy
Cognitive-Behavioral Therapy (CBT)
Interpersonal Therapy
Psychodynamic Therapy
Mood disorders show a higher positive response to treatment than other psychological conditions.
Profile: Male, late 40s, tradesperson with Major Depressive Disorder (MDD), undergoing divorce, potential attachment disturbance.
Approximately one-third of individuals with unipolar depression enter treatment yearly.
Behavioral Therapy
Developed by Lewinsohn in the 1970s, emphasizes the link between mood and life rewards.
Focuses on reintroducing enjoyable activities, reinforcing positive behaviors, and social skills development.
Cognitive Therapy
Proposed by Beck, indicates that negative thinking patterns lead to depression.
Combats maladaptive attitudes and addresses the cognitive triad: negative views of self, world, and future.
Treatment involves recognizing and changing these cognitive distortions across four phases.
Mindfulness-Based Cognitive Therapy (MBCT): Teaches disengagement from negative thinking, shown to reduce relapse rates.
Cumulative Data: Curves show significant difference in relapse rates between MBCT and treatment-as-usual.
Combining drug treatments with psychosocial interventions often leads to better outcomes in severe depression cases.
Individual treatment preferences may dictate the optimal approach.
Common biological treatments:
Antidepressants, often involving Tricyclics, MAOIs, and SSRIs.
Electroconvulsive Therapy (ECT): Effective for severe cases when drugs fail.
Transcranial Magnetic Stimulation and Brain Stimulation are alternatives when traditional approaches do not work.
Nearly 70% of major depression patients utilize antidepressants, showing a 60% effectiveness rate (Comer, 2010).
Following treatment cessation within four months, relapse rates exceed 50% (Barlow et al., 2006).
Canada has seen a dramatic increase in antidepressant use from 3.2 million to 14 million between 1981 and 2000.
Serious interactions with tyramine-rich foods can cause dangerously high blood pressure.
New formulations such as skin patches mitigate some side effects associated with traditional MAOIs.
Clinical studies show a majority of patients benefit significantly when adhering to treatment plans longer than a few weeks.
The risk of relapse is notably reduced with extended use (‘continuation therapy’).
Selective Serotonin Reuptake Inhibitors (SSRIs): Designed to work specifically on serotonin receptors, these drugs show favorable safety profiles compared to earlier antidepressants.
Cognitive, cognitive-behavioral, interpersonal, and biological therapies are all effective for various degrees of depression severity.
Maintenance of therapeutic benefits is crucial as none are entirely relapse-proof.
Effective self-monitoring, medication compliance, and social support are fundamental in preventing relapse.
Lifestyle modifications and booster sessions can aid in sustained management of depressive symptoms.
Prior to recent advancements, treatment options were limited and often ineffective, with high relapse rates.
Lithium and mood-stabilizing drugs provide significant relief, though close monitoring is necessary to avoid toxicity.
Adjunctive Psychotherapy is used due to the insufficient response from medication alone in many patients.
This therapy incorporates aspects like medication management and social skills training.
Daily logs are utilized to track social activities to promote rhythm stability, which is vital in managing bipolar disorders.
This structured approach to treatment offers a comprehensive understanding of various therapies for mood disorders, underlining the importance of individualization and multifaceted treatment plans.